Evidence map›Paper›PMID 36564392›Full record

ArticleScientific reports2022

Surveillance of hemodialysis related infections: a prospective multicenter study.

Imran Hasanoglu, Rahmet Guner, Suzan Sahin, Fatma Yılmaz Karadag, Ergun Parmaksiz, H Veli Atalay, Sabahat Alısır Ecder, Tugba Arslan Gulen, Zuhal Atan Ucar, Oguz Karabay and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Imran HasanogluDepartment of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Yildirim Beyazit University School of Medicine, Bilkent, Ankara, Turkey. ihasanoglu@aybu.edu.tr.ORCID 0000-0001-6692-3893
Rahmet GunerDepartment of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Yildirim Beyazit University School of Medicine, Bilkent, Ankara, Turkey.
Suzan SahinDepartment of Infectious Diseases and Clinical Microbiology, Dr. Lütfi Kırdar Kartal Education and Research Hospital, Istanbul, Turkey.
Fatma Yılmaz KaradagDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University, Sancaktepe Sehit Professor Doctor Ilhan Varank Education and Research Hospital, Istanbul, Turkey.
Ergun ParmaksizDepartment of Nephrology, Dr. Lütfi Kırdar Kartal Education and Research Hospital, Istanbul, Turkey.
H Veli AtalayDepartment of Nephrology, Gulhane Education and Research Hospital, Ankara, Turkey.
Sabahat Alısır EcderDepartment of Nephrology, Prof. Dr. Suleyman Yalcın City Hospital Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Tugba Arslan GulenDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences Adana City Hospital, Adana, Turkey.
Zuhal Atan UcarDepartment of Nephrology, Liv Hospital Vadistanbul, Istanbul, Turkey.
Oguz KarabayDepartment of Infectious Diseases and Clinical Microbiology, Sakarya University, Sakarya, Turkey.
Savas SipahiDepartment of Nephrology, Sakarya University, Sakarya, Turkey.
Esra Kaya KılıcDepartment of Infectious Diseases and Clinical Microbiology, Ankara Education and Research Hospital, Ankara, Turkey.
Murat DuranayDepartment of Nephrology, Ankara Education and Research Hospital, Ankara, Turkey.
Derya YaparDepartment of Infectious Diseases and Clinical Microbiology, Hitit University, Çorum, Turkey.
İbrahim DoganDepartment of Nephrology, Hitit University, Çorum, Turkey.
Gulden ErsozDepartment of Infectious Diseases and Clinical Microbiology, Mersin University Hospital, Mersin, Turkey.
Gulcan TurkmenDepartment of Infectious Diseases and Clinical Microbiology, Mersin University Hospital, Mersin, Turkey.
Ahmet Alper KıykımDepartment of Nephrology, Mersin University Hospital, Mersin, Turkey.
Mersin Üniversitesi · TRAnkara Yıldırım Beyazıt University · TRDr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TRHitit Üniversitesi · TRSağlık Bilimleri Üniversitesi · TRSakarya University · TRGülhane Askerî Tıp Akademisi · TRIstanbul Medeniyet University · TRLiv Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As in many countries, there is neither a surveillance system nor a study to reveal the hemodialysis (HD) related infection rates in Turkey. We aimed to investigate the infection rate among HD outpatients and implement CDC's surveillance system. A multicenter prospective surveillance study is performed to investigate the infection rate among HD patients. CDC National Healthcare Safety Network (NHSN) dialysis event (DE) protocol is adopted for definitions and reporting. During April 2016-April 2018, 9 centers reported data. A total of 199 DEs reported in 10,035 patient-months, and the overall DE rate was 1.98 per 100 patient-months. Risk of blood culture positivity is found to be 17.6 times higher when hemodialysis was through a tunneled catheter than through an arteriovenous fistula. DE rate was significantly lower in patients educated about the care of their vascular access site. Staphylococcus aureus was the most causative microorganism among mortal patients. Outcomes of DEs were hospitalization (73%), loss of vascular access (18.2%), and death (7.7%). This first surveillance study revealed the baseline status of HD related infections in Turkey and showed that CDC National Healthcare Safety Network (NHSN) DE surveillance system can be easily implemented even in a high workload dialysis unit and be adopted as a nationwide DE surveillance program.

Indexed as

Catheter-Related InfectionsCentral Venous CathetersStaphylococcal InfectionsHumansOutpatientsProspective StudiesRenal Dialysis

Identifiers

PMID36564392
PMCPMC9789026
OpenAlexW4312155298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.